Regencell Bioscience Holdings Limited Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Regencell Bioscience Holdings Limited
Access all reports
Regencell Bioscience Holdings Limited is a biotechnology company focused on developing traditional Chinese medicine-based treatments for neurocognitive disorders and degenerative conditions. The company’s research aims to address conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), utilizing natural and holistic treatment approaches. Regencell's therapies are grounded in traditional medical practices, combined with modern scientific methods, to offer alternative treatment options for patients with these neurological conditions. The company is headquartered in Hong Kong, and its shares are listed on the Nasdaq.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
RGC
Country
🇺🇸 United States